Estimated prevalence ranges from under 1% to 4%. These numbers are likely underestimated because of under-reporting and misdiagnosis. The onset of the condition is commonly between puberty and age 40, most frequently from age 21 to 29. Women are more commonly affected than men in an approximate ratio of 3 to 1. There is a lack of evidence to show a pattern of racial or ethnic predilection.